Amarin Corp Plcuk (AMRN) EPS (Weighted Average and Diluted) (QoQ) (2011 - 2025)

Amarin Corp Plcuk (AMRN) EPS (Weighted Average and Diluted) (QoQ) (2011 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Amarin Corp Plcuk 6.77 Bn 6.59 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 33.33%
Jun 30, 2025 25.00%
Mar 31, 2025 66.67%
Dec 31, 2024 -100.00%
Mar 31, 2024 0.00%
Dec 31, 2023 60.00%
Sep 30, 2023 -25.00%
Jun 30, 2023 0.00%
Mar 31, 2023 -500.00%
Dec 31, 2022 200.00%
Sep 30, 2022 94.44%
Jun 30, 2022 -125.00%
Mar 31, 2022 -300.00%
Dec 31, 2021 233.33%
Sep 30, 2021 -250.00%
Jun 30, 2021 585.41%
Mar 31, 2021 -141.20%
Dec 31, 2020 150.00%
Sep 30, 2020 -300.00%
Jun 30, 2020 116.67%